Auxly Cannabis Group (CBWTF) AI Stock Analysis

Auxly Cannabis Group

(Other OTC:CBWTF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue and EBITDA growthDouble-digit revenue growth alongside faster adjusted EBITDA growth indicates improving scale and operating leverage. If sustained, this combination can strengthen Auxly’s competitive position, support reinvestment, and increase its ability to fund expansion from internally generated cash.

Negative Factors

Margin compressionThe sharp decline in gross margin shows that recent profitability may be less durable than headline earnings suggest. Higher costs or pricing pressure could constrain reinvestment and cash generation, while weaker unit economics would make future growth more dependent on continued operational improvements.

Auxly Cannabis Group (CBWTF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $271.51M
Dividend Yield: ―
Average Volume (3M): 32.90K
Price to Earnings (P/E): 10.9
Beta (1Y): 0.52
Revenue Growth: 19.86%
EPS Growth: 12.85%
Country: US
Employees: 446
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Auxly Cannabis Group Business Overview & Revenue Model

Company Description

Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and...

Auxly Cannabis Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

CBWTF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:CRON	80Outperform	CAD 1.70B	17.61	6.46%	―	36.21%	264.71%
TSE:OGI	60Neutral	CAD 186.13M	2.05	21.99%	―	38.14%	2030.00%
TSE:ACB	54Neutral	CAD 372.12M	-2.93	-21.00%	―	-18.93%	-472.15%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:WEED	48Neutral	CAD 414.62M	-1.39	-29.85%	―	6.81%	85.26%

* Healthcare Sector Average

Performance Comparison

CBWTF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CBWTF	Auxly Cannabis Group (Otc)	2.63	1.06	67.73%
TSE:WEED	Canopy Growth	0.93	-0.77	-45.29%
TSE:OGI	Organigram Global Inc.	1.32	-0.88	-40.00%
TSE:ACB	Aurora Cannabis (US)	5.66	-1.20	-17.49%
TSE:CRON	Cronos Group (US)	4.62	1.06	29.78%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Auxly Cannabis Group AI Stock Analysis